维普中文期刊产品整合服务
49篇 您的检索式:作者名="Soardo"
    题名 作者 年代 出处 被引量
1Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study显示文摘BACKGROUND Direct-acting antiviral agents(DAAs)are extremely effective in eradicating hepatitis C virus(HCV)in chronically infected patients.However,the protective role of the sustained virologic response(SVR)achieved by second-and thirdgeneration DAAs against the onset of hepatocellular carcinoma(HCC)and mortality is less well established.AIM To examine the occurrence of HCC or death from any cause in a retrospectiveprospective study of patients treated with DAAs.METHODS Patients were enrolled from a tertiary academic hospital center for liver disease management that collects subject data mainly from northeastern Italy.The study was conducted in 380 patients(age:60±13 years,224 males,32%with cirrhosis)treated with DAAs with or without SVR(95/5%),with a median follow up of 58 wk(interquartile range:38-117).The baseline anthropometric features,HCV viral load,severity of liver disease,presence of extra-hepatic complications,coinfection with HIV and/or HBV,alcohol consumption,previous interferon use,alphafetoprotein levels,and renal function were considered to be confounders.RESULTS The incidence rate of HCC in patients with and without SVR was 1.3 and 59 per 100 person-years,respectively(incidence rate ratio:44,95%CI:15-136,P<0.001).Considering the combined endpoint of HCC or death from any cause,the hazard ratio(HR)for the SVR patients was 0.070(95%CI:0.025-0.194,P<0.001).Other independent predictors of HCC or death were low HCV viremia(HR:0.808,P=0.030),low platelet count(HR:0.910,P=0.041),and presence of mixed cryoglobulinemia(HR:3.460,P=0.044).Considering SVR in a multi-state model,the independent predictors of SVR achievement were absence of cirrhosis(HR:0.521,P<0.001)and high platelet count(HR:1.019,P=0.026).Mixed cryoglobulinemia predicted the combined endpoint in patients with and without SVR(HR:5.982,P=0.028 and HR:5.633,P=0.047,respectively).CONCLUSION DAA treatment is effective in inducing SVR and protecting against HCC or death.A residual risk of HCC persists in patients with advanced liver disease or with complications,such as mixed cryoglobulinemia or renal failure.Gian Luca Colussi Debora Donnini Rosario Francesco Brizzi Silvia Maier Luca Valenti Cristiana Catena Alessandro Cavarape Leonardo Alberto Sechi Giorgio Soardo 2019World Journal of Gastroenterology2019,25,40:4
2Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study显示文摘Mario Pirisi Claudio Avellini Carlo Fabris Cathryn Scott Paola Bardus Giorgio Soardo Carlo A. Beltrami Ettore Bartoli 1998Journal of Cancer Research and Clinical Oncology1998,,:2
3Increased serum resisitin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 显示文摘Pagano C Soardo G Pilon C 2005J Clin Endocrinol Metab2005,91,:1
4Systematic use of recurrent laryngeal nerve neuromonitoring changes the operative strategy in planned bilateral thyroidectomy 显示文摘Sadowski SM Soardo P Leuchter I 2013Thyroid2013,23,3:1
5Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 显示文摘Pagano C Soardo G Pilon C 2006J Clin Endocrinol Metab2006,91,3:1
6Systematic use of recurrent laryngeal nerve neuromonitoring changes the operative strategy in planned bilateral thyroidectomy显示文摘Sadowksi SM Soardo P Leuchter I 2012Thyroid2012,23,3:1
7Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance显示文摘Pagano C Soardo G Pilon C 2006J Clin E ndocrinol Metab2006,91,3:1
8Dependence of power losses on peak magnetization and magnetization frequency in grain-oriented and non-oriented 3%Si Fe显示文摘BERTOTTI G FIORILLO F SOARDO G 1987IEEE Transactions on Magnetics1987,23,5:1
9Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance显示文摘Pagano C Soardo G Pilon C 2006J Clin Endocrinol Metab2006,91,3:1
10Plasma adiponectin is decre-ased in nonalcoholic fatty liver disease显示文摘Pagano C Soardo G Esposito W etal 2005European journal of en- docrinology / European Federation of Endocrine Societies2005,152,1:1
11Circulating and adipose tissue ex-pression of Visfatin in non-alcoholic fatty liver disease显示文摘Soardo G Pagano C Donnini D 2006J Hepatol2006,44,2:1
12Increased serum resisfin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 显示文摘Pagano C Soardo G Pilon C 2006J Clin Endocrinol Metab2006,91,3:1
13Plasma adiponectin is decreased in nonalcoholic fatty liver disease显示文摘Pagano C Soardo G Esposito W 2005Eur J Endocrinol2005,152,1:1
14Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 显示文摘Pagano C Soardo G Pilon C 2006J clin Endocrin Metab2006,91,3:1
15Increased serum Visfatin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 显示文摘Pagano C Soardo G PilIon C 2006J Clin Endocrinol Metab2006,91,3:1
16Plasma adiponectin is decreased in nonalcoholic fatty liver disease显示文摘Pagano C Soardo G Esposito W 2005Eurl Endocrinol2005,152,1:1
17Dependence of power losses on peak magnetization and magnetization frequency in gain-oriented and non-oriented 3% SiFe显示文摘BERTOTYI G FIORILLO F SOARDO G P 1987IEEE Transactions on Magnetics1987,23,5:1
18Plasma adiponectin is decreased in nonalcoholic fatty liver disease 显示文摘Pagano C Soardo G Esposito W 2005Eur J Endocrinol2005,152,:1
19Effects of alcohol with- drawal on blood pressure in hypertensive heavy drinkers显示文摘Soardo G Donnini D Varutti R 2006J Hypertens2006,24,8:1
20Increased serum resis- tin in nonalcoholic fatty liver disease is related to liver disease severity and not toinsulin resistance显示文摘Pagano C Soardo G Pilon C 2006J Clin En- docrinol Metab2006,91,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费